Amyloid as a depot for the formulation of long-acting drugs
2008

Using Amyloids to Create Long-Acting Drugs

Sample size: 23 publication 10 minutes Evidence: high

Author Information

Author(s): Samir K. Maji, David Schubert, Catherine Rivier, Soon Lee, Jean E. Rivier, Roland Riek

Primary Institution: The Salk Institute for Biological Studies

Hypothesis

Amyloids can be used as stable depots for the controlled release of long-acting peptide drugs.

Conclusion

Amyloids can effectively serve as a source for the sustained release of biologically active peptides, enhancing the duration of action of certain drugs.

Supporting Evidence

  • Amyloids can act as stable reservoirs for peptide drugs.
  • Long-acting GnRH analogs formed amyloid fibrils that released peptides slowly.
  • Subcutaneous injection of amyloid-forming GnRH analogs resulted in prolonged drug action.

Takeaway

Researchers found that special protein structures called amyloids can help medicines work longer by slowly releasing the active parts of the drug.

Methodology

The study involved testing a family of GnRH analogs for their ability to form amyloids and their release profiles in vitro and in vivo.

Potential Biases

Potential bias in the selection of GnRH analogs and their testing conditions.

Limitations

The study primarily focused on a specific class of peptide drugs and may not be generalizable to all peptide or protein drugs.

Participant Demographics

Adult male Sprague-Dawley rats were used for in vivo experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pbio.0060017

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication